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ABSTRACT
Background and Objectives: Cigarette smoking has been reported to be associated with 
arterial stiffness. However, the clinical relevance of smoking cessation on arterial stiffness is 
debatable. Thus, we evaluated whether smoking cessation is associated with arterial stiffness.
Methods: A total of 1,169 male participants aged 30–64 years with absence of cardiovascular 
diseases in 2013–2017 were selected from the Cardiovascular and Metabolic Disease Etiology 
Research Center cohort study. The subjects were classified into the following 5 groups based 
on self-reporting: non-smokers, former smokers (<1, 1 to <10, and ≥10, years after cessation), 
and current smokers. Arterial stiffness was assessed using the augmentation index (AIx). 
The radial artery AIx was obtained from the peripheral artery waveform. The association was 
explored cross-sectionally.
Results: The AIx of former smokers did not differ from that of non-smokers (p=0.089). 
However, after former smokers were stratified by duration of smoking cessation, we noted a 
linear trend according to the smoking status (p<0.001). Men who quit smoking <1 year ago 
showed an elevated AIx (β=3.94, standard error=1.54, p=0.011) as much as ones of current 
smokers (β=4.39, standard error=0.74, p<0.001), while those who quit more than a decade 
ago showed an AIx similar to that of non-smokers (β=0.35, standard error=0.82, p=0.670) 
after controlling covariates.
Conclusions: A dose-response association between smoking cessation and AIx was revealed, 
which implies the possibility of a reversible effect of smoking cessation on arterial stiffness. 
Therefore, our findings may motivate current smokers to modify their smoking habits to 
delay or reverse disease progression.
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INTRODUCTION
Tobacco use remains a common habit with increasing numbers worldwide. Although 
there has been a steady global reduction in the prevalence of daily smoking since 1980, 
a significant elevation in the number of smokers has been reported concurrently due to 
population growth.1) In particular, Korea is a country with a high prevalence of daily smoking 
and high cigarette consumption.1) Cigarette smoking is a well-known risk factor of the 
progression of cardiovascular diseases (CVDs),2) and arterial stiffness may play a underlying 
pathophysiological mechanism.3)
Smoking is a modifiable lifestyle risk factor for CVD unlike the other risk factors, such as age, 
sex, and ethnicity.4) Cigarette smoking is related with arterial stiffness,3) however, the effect 
of smoking cessation on arterial stiffness has not been clarified. One UK study reported 
a significant reduction in augmentation index (AIx) in successful quitters 4 weeks after 
smoking cessation compared to relapsed smokers.5) In contrast, no significant difference was 
investigated in brachial-ankle pulse wave velocity between baseline and 12 months later in a 
Chinese primary care clinical study.6) Another Netherland study reported 2 years of smoking 
cessation did not significantly affect to a lower progression in intima-media thickness nor to 
an improved results of dynamic vessel wall properties.7) It remains unclear whether smoking 
cessation is protective for the development of the arterial stiffness.
Therefore, this study aimed to investigate whether there is an association between smoking 
cessation and arterial stiffness assessed using radial AIx, an estimate of vascular wave 
reflection and provides a comprehensive assessment of arterial stiffness.
METHODS
The Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) study 
constructed 2 prospective cohorts, a cohort consisting of a general population (the CMERC 
cohort) and high-risk patients (CMERC-HI cohort). This cross-sectional study obtained 
baseline data from the CMERC cohort. Korean adults aged 30–64 years who were free of 
myocardial infarction, heart failure, or stroke participated in this study. All participants 
completed health questionnaires and examinations. The sampling and measurement 
procedures in the CMERC cohort have been described in detail previously.8) Data were 
collected from 4,060 participants (1,426 men, 2,634 women) between the 2013 and 2017 
baseline survey and final analyses were available for 1,169 men. Women were excluded due to 
the small number of smoking history (n=2,634). Participants taking antihypertensive drugs 
(n=254) due to its effect on blood pressure and those for whom key variables were missing 
(n=3) were also excluded.
Information on demographic health-related behaviors and medical history were obtained 
based on participants' self-reports through a face-to-face interview. Physical activity was 
evaluated using the International Physical Activity Questionnaire-Short Form - Korean 
version,9) which consists of walking frequency and duration, moderate-intensity activity, 
vigorous activity, and sedentary activity during the past 7-day. Participants were stratified into 
3 groups based on sedentary time (<4, ≥4 and <7, ≥7 hours/day). Participants were classified 
as current regular alcohol drinkers, former drinkers, or non-drinkers. History of diseases 
such as diabetes and hypertension was identified through self-reporting of a physician's 
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diagnosis. Current medication information was also obtained from the participants. People 
using anti-hypertensive medications were not included for the present study. Physical 
examinations including measurements of body size, composition, and blood pressure were 
conducted by trained research personnel. Participants rested for ≥5 minutes before the blood 
pressure measurement, and systolic blood pressure (SBP) and diastolic blood pressure (DBP) 
were repeatedly measured 3 times at 2-minute intervals in the right arm using an automated 
oscillometric device (HEM-7080; Omron Health, Matsusaka, Japan). The mean blood 
pressure of second and third-time measurements was used in the analysis. Pulse pressure 
(PP) was attained from the difference between SBP and DBP. Biochemical analyses of a 
fasting blood sample were assessed in the baseline CMERC cohort.
All participants were interviewed using standardized questionnaires to obtain information 
regarding cigarette smoking. Trained interviewers conducted face-to-face interviews and 
questionnaire surveys according to the protocol. Details about lifetime smoking experience, 
current smoking, and smoking amount and duration were obtained from individuals. 
Smoking status was self-reported as current, former, or non-smoker. Former smokers were 
categorized into 3 subgroups according to years since smoking cessation: < 1, 1 to <10, and 
≥10. The cumulative smoking exposure (i.e., smoking pack-years [SPY]) was calculated from 
self-reports of cigarette smoking from the questionnaire. Cumulative smoking exposure was 
estimated as daily packs smoked multiplied by the number of years smoked.
Arterial stiffness was assessed by radial AIx, which was calculated using a non-invasive device 
(HEM-9000AI; Omron Healthcare Co., Ltd., Kyoto, Japan). The participants were asked to 
assume a seated position after taking at least a 5-minute rest and remain still and relaxed 
during all measurements. Radial AIx was calculated as follows: (Second peak SBP−DBP)/
(First peak SBP−DBP)×100 (%).10)
Since radial AIx was affected by heart rate, the index was corrected to 75 beats/minute. 
Waveform data were confirmed by well-trained technicians.
Statistical analyses
We used the analysis of variance for normally distributed continuous variables, the Kruskal-
Wallis test for skewed distributed variables, and the χ2 test for categorical variables to 
compare the demographic characteristic of individuals according to 5 smoking status 
groups. Adjusted means of AIx was attained from using analysis of covariance. First, the 
associations between smoking status (non-smokers [reference group], former smokers, 
and current smokers) and arterial stiffness, AIx, was investigated by multivariate linear 
regression. Adjustments were made for age, height, weight, SBP, DBP, diabetes diagnosis, 
low-density lipoprotein cholesterol, alcohol intake, and sedentary time. Second, subgroup 
analyses stratified by smoking status according to the duration of smoking cessation (non-
smokers [reference group], former smokers [<1, 1 to <10, ≥10 years], and current smokers) 
were conducted. Third, whether there were multiplicative interactions between former 
smoking status and cumulative smoking exposure (SPY, continuously) or age (<55, ≥55) was 
investigated, and linear trends according to smoking status, from non-smokers to current 
smokers, were also examined.
We conducted several sensitivity analyses. First, we performed subgroup analyses to 
investigate cumulative smoking exposure. Former smokers were stratified into 3 groups 
according to tertile value of smoking pack-years (≤8, >8 and <20, and ≥20). Second, to 
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examine whether our findings differed by the duration of smoking cessation, we applied 
various cutoffs. Third, to examine whether our findings differed from the participants who 
took anti-hypertensive medication, we included those participants in the analyses. Fourth, 
we conducted the analysis also for the female participants (n=2,257) after excluding the ones 
with taking anti-hypertensive medication. All statistical analyses were performed using SAS 
software version 9.4 (SAS Institute, Inc., Cary, NC, USA).
Ethics
Informed consent was obtained from all participants. The study protocol was approved by the 
Institutional Review Board of Severance Hospital (YUIRB-4-2013-0661).
RESULTS
The general characteristics of the study participants stratified by smoking status are 
presented in Table 1. The mean age of the former smokers (52.1 years) was higher than that 
of the non-smokers (47.8 years) and current smokers (45.7 years). Former smokers tended 
to have higher SBP, DBP, PP, and AIx values than the current and non-smokers. In addition, 
there was a linear trend of AIx according to smoking status.
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Table 1. Descriptive characteristics of study participants
Variables
Smoking status
p value p for trendNon-smoker  
(n=271)
Former smokers, duration of cessation (years) Current smoker  
(n=420)<1 (n=42) 1 to <10 (n=157) ≥10 (n=279)
Age (years) 47.8±11.1 45.1±10.6 48.0±9.8 55.4±7.3 45.7±9.8 <0.001 0.873
BMI (kg/m2) 24.4±2.8 25.6±3.1 24.9±2.6 24.3±2.5 24.9±3.2 0.004 0.139
Waist (cm) 84.6±7.4 88.3±8.0 86.8±7.5 85.7±6.9 86.9±8.5 0.001 0.003
SBP (mmHg)* 122.4±12.7 125.8±14.5 125.4±12.0 126.3±14.8 123.8±13.9 0.010 0.136
DBP (mmHg)* 79.4±9.8 82.1±11.0 81.4±9.7 81.3±9.6 80.2±10.8 0.095 0.346
Pule pressure (mmHg) 43.0±6.6 43.7±7.5 43.9±6.9 45.0±9.8 43.6±7.9 0.059 0.176
AIx75 (%) 72.2±12.8 75.1±11.5 74.5±11.4 77.1±11.1 75.1±11.2 <0.001 <0.001
Total cholesterol (mg/dL) 194.5±35.1 195.3±34.6 205.2±32.2 196.7±35.9 198.2±33.9 0.036 0.299
HDL cholesterol (mg/dL) 51.9±12.4 50.6±14.4 52.6±12.5 52.7±12.6 50.7±13.1 0.249 0.356
LDL cholesterol (mg/dL) 119.1±32.1 120.0±32.5 125.8±30.7 121.5±32.2 121.6±33.4 0.376 0.425
Triglyceride (mg/dL) 112 (78–162) 133 (71–132) 139 (72–120) 114 (73–135) 146 (99–212) <0.001 0.001
HbA1c (%) 5.5 (5.2–5.7) 5.5 (5.3–5.8) 5.5 (5.2–5.6) 5.6 (5.1–5.6) 5.5 (5.3–5.8) 0.007 0.001
Fasting insulin (uIU/mL) 8.3 (6.3–10.0) 10.0 (6.3–9.8) 9.3 (6.4–9.6) 8.1 (6.5–9.3) 8.5 (6.5–11.0) 0.001 0.660
Fasting glucose (mg/dL) 88 (83–94) 89 (81–92) 92 (80–91) 92 (79–90) 90 (83–98) <0.001 0.001
Diabetes mellitus (%) 8 (3) 1 (2) 5 (3) 10 (4) 9 (2) 0.797 0.639
Hypertension† (%) 12 (4) 2 (5) 6 (4) 22 (8) 28 (7) 0.325 0.150
Physical activity (days/week) 0.394
None 176 (65) 33 (80) 105 (67) 176 (63) 295 (70)
≤3 71 (26) 6 (15) 37 (24) 69 (25) 90 (21)
>3 24 (9) 3 (7) 15 (10) 34 (12) 35 (8)
Drinking <0.001
Never 43 (16) 4 (10) 14 (9) 21 (8) 22 (5)
Formerly 22 (8) 1 (2) 4 (3) 33 (12) 4 (1)
Currently 206 (76) 37 (90) 139 (89) 225 (81) 394 (94)
Sedentary time (hours/day) 0.854
≤4 77 (28) 13 (32) 41 (26) 81 (29) 132 (31)
4–7 72 (27) 11 (27) 52 (33) 79 (28) 113 (27)
>7 122 (45) 18 (44) 64 (41) 119 (43) 174 (41)
Values are presented as mean±standard deviation or number (%).
AIx75 = augmentation index adjusted for 75 beat/minute; BMI = body mass index; DBP = diastolic blood pressure; HbA1c = hemoglobin A1c; HDL = high density 
lipoprotein; LDL = low density lipoprotein; SBP = systolic blood pressure.
*Obtained from upper-arm blood pressure; †Hypertensive patients but not taking anti-hypertensive medication.
Table 2 presents the association between smoking status and arterial stiffness. Current 
smokers showed significantly higher AIx (β=4.34, standard error=0.74, p<0.001) compared 
to non-smokers, but not in former smokers (β=1.23, standard error=0.72, p=0.089). After 
considering duration of smoking cessation, the altered association was investigated between 
former cigarette smoking and arterial stiffness. A significant increase in AIx in individuals 
who quit smoking less than 1-year prior (β=3.94, standard error=1.54, p=0.011) and those 
with a duration of 1–9 years (β=1.87, standard error=0.94, p=0.047) compared to non-
smokers. In addition, a linear trend of AIx according to smoking status considering the 
duration of smoking cessation was found (p<0.001). Figure 1 shows the adjusted mean AIx 
values according to the smoking status. There was a dose-response elevation of AIx that those 
who quit smoking for a shorter duration showed higher values. There were no significant 
multiplicative interactions between former smoking status and smoking pack-years (p=0.101) 
or age (p=0.366). In sensitivity analyses using cumulative smoking exposure, different 
durations of smoking cessation categorized by former smoking status, and including subjects 
taking anti-hypertensive medication, similar results were obtained (Supplementary Figure 1). 
In addition, the results of the female participants mostly aligned with those of the primary 
analyses except that former smokers less than a year showed a lower AIx value compared to 
non-smokers (Supplementary Table 1).
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Table 2. Association between smoking status and augmentation index
Smoking status Number
Age adjusted model Age and BP adjusted model Fully adjusted model*
β (SE) p value β (SE) p value β (SE) p value
Non 271 Reference Reference Reference
Former 478 1.65 (0.80) 0.039 0.99 (0.76) 0.191 1.23 (0.72) 0.089
Current 420 4.05 (0.81) <0.001 3.80 (0.77) <0.001 4.34 (0.74) <0.001
Non 271 Reference Reference Reference
Former, ≥10 years quitting 279 0.82 (0.91) 0.374 0.21 (0.87) 0.810 0.35 (0.82) 0.670
Former, 1 to <10 years quitting 157 2.21 (1.04) 0.034 1.54 (0.98) 0.119 1.87 (0.94) 0.047
Former, <1 year quitting 42 4.27 (1.72) 0.011 3.37 (1.63) 0.039 3.94 (1.54) 0.011
Current 420 4.08 (0.81) <0.001 3.83 (0.77) <0.001 4.39 (0.74) <0.001
p for linear trend <0.001 <0.001 <0.001
BP = blood pressure; SE = standard error.
*Fully adjusted model was adjusted for age, systolic blood pressure, diastolic blood pressure, height, weight, diabetes diagnosis, low-density lipoprotein 





Duration of smoking cessation (year)
1 to <10
(n=157)



















Figure 1. Adjusted means of augmentation index according to smoking status. Adjusted for age, systolic blood 
pressure, diastolic blood pressure, height, weight, diabetes diagnosis, low-density lipoprotein cholesterol, 
alcohol intake, and sedentary time. 
AIx75 = augmentation index adjusted for 75 beat/minute. 
*Statistically significant compared to non-smokers (p<0.05).
DISCUSSION
The present study investigated that the AIx of former smokers did not differ significantly 
from that of non-smokers. However, the dose-response association between smoking 
cessation and AIx was revealed after considering the duration of smoking cessation. The 
shorter the duration after smoking cessation, the higher were the AIx values. In particular, 
participants who quit smoking less than 1-year prior showed similar AIx values to those of 
current smokers, while those who quit smoking more than a decade prior showed AIx values 
similar to those of non-smokers.
Arterial stiffness improved in former smokers according to cessation duration. In other 
words, former smokers who abstained from smoking for >10 years showed a reduction in 
arterial stiffness to the level of non-smokers, pointing toward improved vascular function. 
Although it is hard to conclude the definite duration of smoking cessation needed to reverse 
arterial stiffness, the longer duration of cessation seemed to benefit the arterial stiffness in 
our study. In our sensitivity analyses, various cutoffs of smoking cessation years were applied 
and ≥10 years of smoking cessation found to be the most similar level of AIx compared with 
that of non-smokers among various cutoff values. Our finding that former smokers with a 
longer duration of smoking cessation had a similar level of arterial stiffness compared to 
non-smokers is consistent with previous studies. According to the cross-sectional study 
of hypertensive patients, the duration of smoking cessation was significantly related to 
improvements in arterial stiffness including pulse wave velocity, AIx, and transit time.11) 
Another UK study of 20 patients who participated in the smoking clinic at a hospital found 
that successful smoking quitters had significant reductions in AIx after 4 weeks of tobacco 
smoking abstinence compared to relapsed smokers.5)
Arterial stiffness can be determined by 3 components of the arterial wall: first, quantitative 
structural components such as the proportion of elastin and collagen; second, qualitative 
structural components such as cross-linking of glycated collagen; and third, functional 
components such as vasoconstrictor tone exercised by smooth muscle cells.4) Smoking can 
affect every physiological aspect of arterial stiffening through many potential mechanisms, 
such as endothelial dysfunction, increased oxidative stress, and inflammation.2) A relevant 
mechanism related to the reversible smoking cessation effect is the autonomic nervous 
system (ANS) activated by smoking exposure.12) The elevated ANS is correlated with increased 
blood pressure and peripheral resistance, a result of the concurrent interaction with the 
weakened baroreflex sensitivity that accompanies aging.13) Through acute smoking exposure, 
nicotine leads to a predominance of sympathetic nerve activity12) that can contribute to 
the risk of peripheral vasoconstriction and an accelerated heart rate.14) Several studies in 
agreement with our result reported the possibility of a reversible effect of smoking cessation 
in relation to the sympathetic nervous system. Chronic habitual smokers15) and heavy 
smokers16) showed improved results in heart rate variability, a measure of the interplay 
between the sympathetic and parasympathetic nervous systems, within 7 days of smoking 
cessation. In addition, the sympathetic nerve activity patterns of former smokers were not 
distinguished from those of non-smokers, which had an implication that smoking effect may 
be reversible to the normalized sympathetic nerve activity.17)
The changeable effect of smoking cessation on arterial stiffness may also be explained by the 
role of nitric oxide synthesis related to the sympathetic nervous system.18) Impaired nitric 
oxide synthesis is reportedly a detrimental factor in the regulation of vasomotor tone and 
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blood pressure19) through a loss of vasodilator tone at the vascular smooth muscle cells and 
by progressing central neural vasoconstrictor outflow.20) The central action of nitric oxide, 
reducing sympathetic vasoconstrictor outflow to the sympathetic neurons, and peripheral 
action of nitric oxide, directly decreasing peripheral vascular smooth muscle tone, contribute 
to vasodilation or decreased arterial stiffness.20) One study supports the fact that the effect of 
smoking cessation is correlated with a normalized nitric oxide level. By achieving smoking 
cessation, the plasma nitric oxide concentration in former smokers was not significantly 
different from that of the non-smokers.21) Another study reported that the elevated oxidative 
stress assessed by the level of nitric oxide gradually return to normal after a long period of 
smoking cessation.22) In addition, several studies reported the interactions between nitric 
oxide and cardiac autonomic control in animal data23) or human data.24) Nitric oxide appears 
to work as a sympatholytic agent,23) attenuating central sympathetic outflow and lowering 
cardiac responses to sympathetic stimulation.25) Considering the moderating role of nitric 
oxide on the sympathetic nervous system, it is reasonable to assume that there might be a 
reversible effect of smoking cessation on arterial stiffness through an ANS mechanism.
However, there are several limitations should be considered. First, as in all cross-
sectional studies, we cannot conclude that there is a causal effect of smoking cessation 
on AIx. Unmeasured factors such as environmental smoking may be responsible for 
this relationship.26) Second, we utilized the radial AIx, a surrogate measurement of wave 
reflection. there are some data supporting that radial AIx reflects vascular stiffening and 
aging,10) it may not be considered as a standard measurement of arterial stiffness.27) Third, 
smoking information including current status, duration of smoking cessation, and the 
number of cigarettes smoked were self-reported, which might lead to some misclassification 
bias. However, the validity of self-reported smoking status had been proven through many 
studies.28)29) Fourth, the interpretation of results in this study is limited to male participants. 
However, in spite of the limited statistic power, we found a similar trend of results with 
primary analyses in sensitivity analyses with female participants. Fifth, the analyses were 
based on small numbers of former smokers who quit smoking more than 10 years prior, 
which limited the power of our statistical analysis. Finally, we found no study, in the 
literature, evaluating the simultaneous changes on nitric oxide synthesis and sympathetic 
nervous system, and this could limit our explanation of possible mechanisms.
We found a significant dose-response association between the duration of smoking cessation 
and AIx in male subjects recruited from the general population. Therefore, our findings 
may help inspire current smokers to modify their smoking habits to delay or reverse disease 
progression. Nonetheless, the effect of smoking cessation on arterial stiffness should be 
further evaluated in longitudinal studies in the future.
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SUPPLEMENTARY MATERIALS
Supplementary Table 1
Association between smoking cessation and augmentation index in women
Click here to view
Supplementary Figure 1
Association between smoking cessation and augmentation index according to cumulative 
smoking exposure, different cutoffs of former smokers, and including subjects taking anti-
hypertensive medication. Data are presented as β (95% confidence interval) of subjects. 
Fully adjusted model was adjusted for age, systolic blood pressure, diastolic blood pressure, 
height, weight, diabetes diagnosis, low-density lipoprotein cholesterol, alcohol intake, and 
sedentary time.
Click here to view
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